Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending June 25, 2003. The report details corporate actions regarding share re-purchases and updates on directors' interests in company shares.
Key Financial Metrics
The filing does not provide comprehensive financial statements, revenue, profit, cash flow, margins, debt, or liquidity metrics. The only financial data disclosed relates to a specific share transaction:
- Shares Repurchased: 1,200,000 ordinary shares.
- Price per Share: 1,247.7361p.
- Purpose: Purchase for cancellation.
Material Changes
The filing reports the following material changes and transactions:
- Share Capital Reduction: On June 24, 2003, the company executed a share buyback authorized by shareholders at the Annual General Meeting on May 19, 2003.
- Directors' Interests: The GSK Trust transferred a total of 6,837 ordinary shares to participants in the SmithKline Beecham Employee Share Option Plan 1991 on June 20 and June 23, 2003.
Guidance, Outlook, and Risks
The filing text does not provide management commentary, future guidance, outlook, risk factors, contingencies, or unusual items beyond the routine disclosure of the share buyback and trust transfers.
Investor Verification Points
- Verify the total number of shares repurchased for cancellation against the company's authorized buyback limit from the May 19, 2003 AGM.
- Confirm the impact of the 1,200,000 share cancellation on the total outstanding share count.
- Review the full details of the SmithKline Beecham Employee Share Option Plan 1991 to understand the context of the trust transfers.